baber/WOPTO huggingface dataset:
Patent CA-2774049-A1 (CA)
Title: Conference progress supporting apparatus
Inventor: IGA SOICHIRO
IPC: G06F13/00
Filed: 2010-09-27
Abstract: A disclosed conference progress supporting apparatus includes a unit to store information indicating each agenda of the conference and information indicating each participant of the conference, a unit to acquire information via an input device, the information indicating a start and an end of a speech of the participant of the agenda, a unit to store progress information in the conference information storage unit, the progress information associating the agenda, the participants, a start time when the information indicating the start is acquired, and an elapsed time since the start time with each other in response to the acquisition of the information indicating the start, and update the progress information by measuring the elapsed time until the information indicating the end is acquired, and a unit to present information indicating a speech status of each of the participants of each of the agendas based on the progress information.
Patent CA-2775353-A1 (CA)
Title: Polypeptides derived from thermoascus crustaceu having cellulolytic enhancing activity and polynucleotides encoding same
Inventor: TANG LAN
IPC: C07K14/37
Filed: 2010-09-30
Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Patent CA-2777245-A1 (CA)
Title: Compositions for treatment of cystic fibrosis and other chronic diseases
Inventor: VAN GOOR FREDRICK F
IPC: A61P19/10
Filed: 2010-10-22
Abstract: The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one compound of Formula I, Formula II, or Formula III. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
Patent CA-2777639-A1 (CA)
Inventor: NEBURCHILOV VLADIMIR
IPC: H01M4/88
Filed: 2010-10-15
Abstract: L'invention concerne une composition catalytique pour une cathode à air destinée à être utilisée dans une pile électrochimique, notamment dans des piles à combustible métal-air, p. ex. zinc-air, à électrolyte alcalin. La composition catalytique comprend un matériau actif CoTMMP et de l'argent, supportés sur du carbone, le rapport entre l'argent et CoTMMP étant de 1:1 à 2,4:1. Les ingrédients optionnels incluent un hydrophobe et un agent de liaison hydrophobe, MnO2, WC/Co ou les deux. La composition catalytique est supportée sur une couche support microporeuse et une mousse ou maille de nickel pour former une cathode à air.
Patent CA-2779489-A1 (CA)
Inventor: SHAH TUSHAR K
IPC: D01F6/60
Filed: 2010-11-02
Abstract: A composition includes a carbon nanotube (CNT)-infused aramid fiber material that includes an aramid fiber material of spoolable dimensions, a barrier coating conformally disposed about the aramid fiber material, and carbon nanotubes (CNTs) infused to the aramid fiber material. The infused CNTs are uniform in length and uniform in density. A continuous CNT infusion process includes:(a) disposing a barrier coating and a carbon nanotube (CNT)-forming catalyst on a surface of an aramid fiber material of spoolable dimensions; and (b) synthesizing carbon nanotubes on the aramid fiber material, thereby forming a carbon nanotube-infused aramid fiber material.
Patent CA-2780362-A1 (CA)
Title: Administration of plant expressed oral tolerance agents
Inventor: DANIELL HENRY
IPC: A61P9/10
Filed: 2010-11-09
Abstract: Protein replacement therapy for patients with hemophilia or other inherited protein deficiencies is often complicated by pathogenic antibody responses, including antibodies that neutralize the therapeutic protein or that predispose to potentially life-threatening anaphylactic reactions by formation of IgE. Using murine hemophilia B as a model, we have developed a prophylactic protocol against such responses that is non-invasive and does not include immune suppression or genetic manipulation of the patient's cells. Oral delivery of coagulation factor IX (F. IX) expressed in chloroplasts, bioencapsulated in plant cells, effectively blocked formation of inhibitory antibodies in protein replacement therapy. Inhibitor titers were mostly undetectable and up to 100-fold lower in treated mice when compared to controls. Moreover, this treatment eliminated fatal anaphylactic reactions that occurred after 4 to 6 exposures to intravenous F. IX protein. While only 20-25% of control animals survived after 6-8 F. IX doses, 90-95% of tolerized mice survived 12 injections without signs of allergy or anaphylaxis. This high-responder strain of hemophilia B mice represents the first hemophilic animal model to study anaphylactic reactions. The plant material was effective over a range of oral antigen doses (equivalent to 5-80 µg recombinant F.IX/kg), and controlled inhibitor formation and anaphylaxis long-term, up to 7 months. Oral antigen administration caused a deviant immune response that suppressed formation of IgE and inhibitory antibodies. This cost-effective and efficient approach to oral delivery of protein antigens to the gut should be applicable to several genetic diseases that are prone to pathogenic antibody responses during treatment.
Patent CA-2781063-A1 (CA)
Title: Combination
Inventor: GILMER TONA
IPC: A61K31/436
Filed: 2010-11-17
Abstract: A novel combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1 - yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mTOR inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of MEK and/or mTOR is beneficial, e.g. cancer.
Patent CA-2783237-A1 (CA)
Title: Method and apparatus for microwave-based liquid vaporization system
Inventor: NOVAK JOHN F
IPC: C07F1/00
Filed: 2010-12-07
Abstract: The invention described herein generally pertains to coupling microwave energy into a tuned multi-section WR-975 waveguide assembly, connected to a waveguide containing a ceramic cylindrical applicator, terminated in a dummy load, for pre-heating fuels to improve vaporization, combustion efficiency, and soot reduction in combustion chamber(s). Designed primarily for processing liquid byproducts produced during biodiesel fuel manufacturing, this invention establishes a charge density in a cross-coupled applicator, according to the applicator's volume, dielectric characteristics of the materials being processed, applied frequency, and voltage. This invention may also be used for preheating or polarization of solids within a pipe-conveyed slurry, such as biosolids, bituminous coal, crude oil sludge, paper pulp or shale oil rock. Finally, this invention may serve as an integral part of a coal gasification process, employing both microwave drying and reduction methods, to produce syngas, hydrogen, and/or liquid fuels.
Patent CA-2783511-A1 (CA)
Title: Lightning protection system for a wind turbine and wind turbine with a lightning protection system
Inventor: LEWKE BASTIAN
IPC: F03D11/00
Filed: 2010-03-03
Abstract: A lightning protection system (13) for a wind turbine (1) having an electrically grounded structure part (2), a main shaft (4) electrically and mechanically connected therewith, a blade hub (8) rotatively connected via a main bearing (6) to the main shaft (4) and blades (12) connected to the blade hub (8), comprises a down-conductor (14) attachable inside a blade (12), a high voltage conductor (15) for guiding lightning current, wherein a first end (15a) of the high voltage conductor (15) is in electrical communication with the down-conductor (14). It further comprises a high voltage contact (22) attachable inside the main shaft (4), wherein a second end (15b) of the high voltage conductor (15) is in electrical communication with the high voltage contact (22) and wherein a lightning current is guided from the down-conductor (14) via the high voltage conductor (15) to the high voltage contact (22).
Patent CA-2788800-A1 (CA)
Inventor: CLESEN ROMAIN
IPC: B23Q11/10
Filed: 2012-09-06
Abstract: The invention relates to a device for feeding a rinsing medium to the tool of a hammer drill, composed essentially of a rotatable and/or axially displaceable drilling tool holding means with at least one supply channel for the rinsing medium, a transfer part (2) interacting with the holding means (1), a housing (3) and a feed means (4) as well as a holding part with a rinsing medium inlet.   In order to extend the service life of the sealing system, it is provided according to the invention that a feed means (4) shaped essentially in an axially symmetrical manner and the associated holding part (5) form a preferably permanently connected component, wherein the feed means (4) has on both sides respectively distally friction bearings (41, 41'), in particular guide belts and seals (42, 42') towards the drilling tool holding means (1) and the holding part (5) is radially displaceable in limits with bending with respect to the housing (3) and/or a fixing ring (31) connected thereto, but is positively fixed tangentially.
Patent CA-2788814-A1 (CA)
Title: Method and apparatus for dry-conveying material for dry gunning application
Inventor: STENDERA JAMES W
IPC: B65B1/04
Filed: 2011-03-16
Abstract: A method and apparatus for conveying dry material for a gunning application make use of a rotary air lock in communication with a material source and an inductor. The material is supplied through the rotary air lock to the inductor under a pressure greater than the outlet pressure of the inductor.
Patent CA-2790847-A1 (CA)
Inventor: MULVIHILL MARK J
IPC: A61K31/437
Filed: 2011-05-16
Abstract: Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
Patent CA-2792360-A1 (CA)
Inventor: KOZLOWSKI EUGENE J
IPC: A23G9/04
Filed: 2011-02-28
Abstract: A food mixing machine (20) has an agitator (25) to mix food in a cup (C). A cup holder (31) is provided with a flexible boot (32) which receives the cup (C). The cup holder (31) is moveable through an opening (90) in the machine (20) and carries a gripping assembly (33) and an actuator assembly (34). The actuator assembly (34) is moveable relative to the gripping assembly (33) and is biased by springs (35) to maintain fingers (56) of the gripping assembly (33) in engagement with the cup (C). When it is desired to release the cup (C), a release assembly (80) overcomes the bias of the springs (35). As the cup holder (31) moves through the opening (90), the area between the cup holder (31) and the opening (90) is sealed by a seal assembly (91) so that food materials cannot go through the opening (90).
Patent CA-2798717-A1 (CA)
Title: Method of providing a volume-mass law for fuel consumption
Inventor: EVRARD JEAN-PHILIPPE
IPC: G01F9/00
Filed: 2012-12-12
Abstract: The invention is related to a method of providing a volume-mass law for determination of a fuel flow rate of an engine, particularly providing a fuel flow rate to a helicopter turbine, comprising the steps of: Determining a sample type of fuel and a start density .rho.0 of said sample type of fuel in said fuel tank using an equation .rho.0=aT+b0, with a and b0 being known for said sample type of fuel and calculating real time offset parameters bn from an algorithm to determine real time densities .rho. of the fuel.
Patent CA-2802208-A1 (CA)
Inventor: TOSTI SILVANO
IPC: C01B4/00
Filed: 2011-06-16
Abstract: An apparatus for recovery of tritium from contaminated gaseous mixtures by means of isotope- exchange processes comprises a container having a preferably cylindrical shape made of steel or other suitable metal or glass, referred to as "module" (1), which contains at least one permeator tube (T) made of metal or metal alloy selectively permeable to hydrogen and its isotopes, wherein said tube (T) is set in cantilever fashion with its free end closed, there being further provided means for applying an axial tensile force on the free end of the permeator tube (T) and means for electrical connection of said free end of said tube (T) to an end flange (FF) of the module (1) adjacent thereto.
Patent CA-2802467-A1 (CA)
Inventor: GLEADOWE JOHN RICHARD YORKE
IPC: B63B35/00
Filed: 2011-06-24
Abstract: A jack-up vehicle having a hull including at least two hull sections (2, 3) interconnected in such manner as to be positionable in an end-to-end relationship having a first vehicle width and for the purpose of movement of the vehicle from one location to another location and to be positionable in a side-by- side configuration having a second vehicle width when at said another location, wherein the first vehicle width is less than the second vehicle width. A jack-up vessel such as this can maintain stability when elevated with square positioning of supporting legs and yet reposition the hull sections to achieve a preferred hull shape for transit from location - to - location at more than twice the usual speed of known jack-up vessels.
Patent CA-2802641-A1 (CA)
Inventor: ARORA NIDHI
IPC: C07D495/04
Filed: 2011-07-08
Abstract: Compounds of the formula I or II: wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
Patent CA-2802792-A1 (CA)
Inventor: ASUMADU-MENSAH ABOAGYEWA
IPC: A23L27/30
Filed: 2011-06-17
Abstract: The present invention relates to products comprising stevia. Products according to the present invention comprise a sweetening agent derived from Stevia rebaudiana that comprises rebaudioside A wherein the product comprises solids from Aspalathus linearis.
Patent CA-2803394-A1 (CA)
Inventor: LEVESQUE DANIEL
IPC: B60L15/04
Filed: 2011-07-20
Abstract: A direct -drive brushless DC motorization apparatus comprises an outer rotor with poles constructed with segments of permanent magnet material alternatively magnetized north and south. The outer rotor is adapted to be part of a wheel and rotating with the wheel about an axis thereof. A stator core of ferromagnetic material is spaced inwardly of said rotor to define a clearance gap with the rotor such that the rotor is rotatable about the stator core. The stator core has forty-two slots and defines teeth therebetween. A three-phase winding with coils of insulated wire is wound around the teeth of the stator core. The three-phase winding is divided in two sets of consecutive teeth for each of the three phases, with each of the two sets of a same phase being diametrically opposed in the stator core.
Patent CA-2804337-A1 (CA)
Title: Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
Inventor: KLEM BJORN
IPC: A61K9/70
Filed: 2011-07-08
Abstract: This invention relates to dry pharmaceutical compositions comprising an active ingredient which is 5-aminolevulinic acid (5-ALA) or a precursor or derivative of 5-ALA, or a pharmaceutically acceptable salt thereof. The compositions may be used in the photodynamic treatment (PDT) or photodynamic diagnosis (PDD) of cancer, pre-cancerous conditions and non-cancerous conditions. The invention relates further to irradiation devices comprising dry compositions and the use of such devices in the photodynamic treatment (PDT) or photodynamic diagnosis (PDD) of cancer, pre-cancerous conditions and non-cancerous conditions.
Patent CA-2808002-A1 (CA)
Inventor: BOSTICK MICHAEL W
IPC: C12P7/64
Filed: 2011-08-26
Abstract: Mutant delta 5 desaturases, having the ability to convert dihomo-gamma-linolenic acid [DGLA; 20:3 omega-6] to arachidonic acid [ARA; 20:4 omega-6] and/or eicosatetraenoic acid [ETA; 20:4 omega-3] to eicosapentaenoic acid [EPA; 20:5 omega-3] and possessing at least one mutation within the HPGG (SEQ ID NO:7) motif of the cytochome b 5-like domain and at least one mutation within the HDASH (SEQ ID NO:8) motif are disclosed. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta 5 desaturases, along with a method of making long chain polyunsaturated fatty acids ["PUFAs"], are also disclosed.
Patent CA-2808696-A1 (CA)
Inventor: GSCHWIND ANDREAS
IPC: C07K16/22
Filed: 2011-09-02
Abstract: VEGF-binding molecules, preferably VEGF-binding immunoglobulin single variable domains like VHHs anddomain antibodies, pharmaceutical compositions containing same and their use in the treatment of diseases that are associated with VEGF- mediated effects on angiogenesis.Nucleic acids encoding VEGF-binding molecules, host cells and methods for preparing same.
Patent CA-2809593-A1 (CA)
Inventor: CLEMEN MARK JOSEPH JR
IPC: B64D15/20
Filed: 2013-03-13
Abstract: A method and apparatus for detecting an icing condition. The apparatus comprises a piezoelectric material and a vibration detector. The piezoelectric material has a surface proximate to a surface of a vehicle. The piezoelectric material is configured to vibrate. The vibration detector is configured to detect a change in vibrations in the piezoelectric material that indicates a presence of an icing condition on the surface of the piezoelectric material.
Patent CA-2809624-A1 (CA)
Inventor: CIANCI CHRISTOPHER W
IPC: A61P31/16
Filed: 2011-09-06
Abstract: A compound of Formula (I) is set forth, including pharmaceutically acceptable salts thereof, wherein Het is a 5 or 6-membered heterocycle with -N, -O, or -S adjacent to the -Ar substituent or adjacent to the point of attachment for the -Ar substituent; Ar is aryl or heteroaryl; R is -CH3, -CH2F, or -CH=CH2; W is -NO2, -Cl, -Br, -CHO, -CH=CH2, or -CN; X is -Cl, -CH3, or -CN; Y is -CH or -N; and Z is C1-C6 alkyl, C3-C6 cycloalkyl, substituted aryl, substituted heteroaryl, OR1, or NHR1, wherein R1 is selected from the group of H, aryl, heteroaryl, C1-C6 alkyl and C3-C6 cycloalkyl. This compound is useful in compositions for the prevention and treatment of influenza virus.
Patent CA-2809722-A1 (CA)
Inventor: UTUKURI AVANINDRA
IPC: G01V8/20
Filed: 2011-09-02
Abstract: Several system for tracking one or more radiation blocking objects on a surface are disclosed. At least three radiation sensors are provided adjacent the surface and a plurality of radiation sources as provided adjacent the surface. Radiation from at least some of the radiation sources can reach each of the radiation sensors. One or more radiation blocking objects on the surface attenuate radiation from one or more radiation sources from reaching each of the sensors. One or more polygons is calculated based on the attenuated radiation sources and the positions of the sensors.  The position of the one or more radiation blocking objects is estimated and may be tracked based on the polygons.
Patent CA-2810475-A1 (CA)
Title: A method for preparing ramipril
Inventor: DESAI PARIMAL
IPC: C07D209/52
Filed: 2011-04-05
Abstract: Enantio-specific synthesis of optically pure (2S)-acetylamino-3-(2-oxo-cyclopentyl)- propionic acid (I) comprising converting enantiomeric mixture of (1 -4C alkyl)-2- acetylamino-3-(2-oxocyclopentyl) propionoate (II) (+ and -) under the influence of an Alkaline serine endopeptidase is disclosed. The invention further describes use of optically pure (2S)-acetylamino-3-(2-oxocyclopentyl)-propionic acid (I) formed by the process of present invention, in the preparation of Ramipril.
Patent CA-2811063-A1 (CA)
Inventor: SCHMIDT FRIEDRICH GEORG
IPC: C08J5/24
Filed: 2011-08-30
Abstract: The invention relates to prepregs, which are chromatically adjusted with pigment or dye preparations, on the basis of a storage-stable reactive or highly reactive polyurethane composition.
Patent CA-2812023-A1 (CA)
Inventor: GIRARD FRANCOIS
IPC: A43C15/06
Filed: 2013-04-02
Abstract: Elément chaussant (1) comprenant un semelage externe (3) et une tige souple (4), ainsi que des pointes (9) qui font saillie au niveau d'une face externe (10) du semelage externe (3), la tige souple (4) comprenant une portion basse (11 ) prévue pour couvrir le pied d'un utilisateur, la tige souple (4) présentant une ouverture de chaussage (25). La tige (4) comprend une portion haute (12) qui prolonge la portion basse (11) dans un sens d'éloignement du semelage externe (3), la portion haute (12) étant prévue pour couvrir au moins la cheville de l'utilisateur, ou la cheville et une partie du bas de jambe.
Patent CA-2812817-A1 (CA)
Title: Method of detoxification of pneumolysin
Inventor: BIEMANS RALPH
IPC: C07K14/195
Filed: 2004-03-11
Abstract: The present invention relates to a method for purifying bacterial cytolysins such as pneumococcal pneumolysin. A single chromatography step produces excellent purification of the cytolysin by binding soluble aggregated cytolysin to a hydrophobic interaction chromatography material in the presence of detergent and high salt.
Patent CA-2813663-A1 (CA)
Inventor: HOLZAPFEL MICHAEL
IPC: H01M4/04
Filed: 2011-11-14
Abstract: The present invention relates to a process for the synthesis of a carbon-deposited alkali metal phosphosilicate cathode material comprising particles, wherein said particles cam', on at least a portion of the particle surface, carbon deposited by pyrolysis, said process comprising a first dry high-energy milling step performed on precursors of said carbon-deposited alkali metal phosphosilicate cathode material prior to a first solid-state thermal reaction, and a second dry high-energy milling step performed on a product of the first thermal reaction prior to a second solid-state thermal reaction.
Patent CA-2814581-A1 (CA)
Title: Sel tosylate de la (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h- 1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phtalazin-3(7h)-one cristallin
Inventor: WANG BING
IPC: A61K31/5025
Filed: 2011-10-20
Abstract: La présente invention concerne des formes du sel tosylate de la (8S, 9R)-5-fluoro-8-(4-fluorophényl)-9-(1-méthyl-lH-1,2,4-triazol-5- yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phtalazin-3(7H)-one, y compris des formes cristallines et leurs procédés de préparation. L'invention concerne également des compositions pharmaceutiques contenant un sel tosylate de la (8S,9R)-5-fluoro-8-(4-fluorophényl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)- 8,9-dihydro-2H- pyrido[4,3,2-de]phtalazin-3(7H)-one ainsi que des méthodes d'utilisation du sel tosylate de la (8S,9R)-5-fluoro-8-(4-fluorophényl)-9- (1-méthyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H- pyrido[4,3,2-de]phtalazin-3(7H)-one pour traiter une maladie ou une affection, telle qu'un cancer.
Patent CA-2818484-A1 (CA)
Inventor: GOTTLIEB EMANUEL J
IPC: G01F1/66
Filed: 2011-11-02
Abstract: A flowmeter includes a container for attaching to a pipe having a channel for gas flow, and a plurality of recesses that extend through the container and a plurality of housings. Each recess has a housing which contains pressure in the channel. Each housing has a window in acoustic communication with the channel. The flowmeter includes a plurality of transducers, with one transducer disposed in each recess. The transducers transmit ultrasonic signals into and receive ultrasonic signals from the channel through the window in the housing in which a transducer is disposed. The flowmeter includes a controller in electrical communication with the transducers, which determines the gas flow rate through the channel by measuring transit times of signals transmitted by and received by the transducers.